1. Home
  2. BNTC vs RCKT Comparison

BNTC vs RCKT Comparison

Compare BNTC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$13.82

Market Cap

454.2M

Sector

Health Care

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.64

Market Cap

394.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
RCKT
Founded
1995
1999
Country
United States
United States
Employees
N/A
202
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
454.2M
394.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNTC
RCKT
Price
$13.82
$3.64
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
$27.67
$29.73
AVG Volume (30 Days)
67.4K
1.5M
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
80.94
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$64.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$2.53
52 Week High
$16.76
$5.45

Technical Indicators

Market Signals
Indicator
BNTC
RCKT
Relative Strength Index (RSI) 64.91 N/A
Support Level $11.31 N/A
Resistance Level $14.35 N/A
Average True Range (ATR) 0.64 0.00
MACD 0.18 0.00
Stochastic Oscillator 91.70 0.00

Price Performance

Historical Comparison
BNTC
RCKT

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: